Entrevest has invested in the Belgian healthtech company Farow, which focuses on improving care for brain disorder patients through innovative digital solutions.

Information on the Target

Entrevest is pleased to announce its investment in Farow, an innovative healthtech company headquartered in Hasselt, Belgium. Farow specializes in developing digital solutions designed to enhance the quality of life for individuals suffering from brain disorders such as epilepsy and Parkinson’s disease. The company, which was previously known as Epihunter, has successfully raised 1.6 million euros in its latest funding round, garnering robust support from both existing and new investors. Entrevest has joined as a strategic investment partner to bolster the company's growth and expansion.

Farow utilizes a unique combination of wearable EEG technology and artificial intelligence to offer therapeutic and non-therapeutic interventions for patients with brain disorders. With this cutting-edge technology, Farow is capable of detecting and monitoring epileptic absence seizures in real time, benefiting not only patients but also their families, educators, and healthcare providers. This advancement contributes significantly to improved care, quicker diagnoses, and more effective, targeted treatment options.

Industry Overview in Belgium

The healthtech industry in Belgium is rapidly advancing, fueled by a strong emphasis on innovation and technological integration in healthcare. With a robust network of universities and research institutions, the country is well-positioned to foster the d